Yi Wang, Ph.D, MBA
Early-stage Fundraising and Business Operation, Data Analytics, Business Development, Public Health
Dr. Wang is an early-stage startup operator and angel investor and a tenured professor. He is a Blavatnik Fellow for commercializing early-stage technologies at Yale University. As an early-stage startup operator at Isolere Bio, he has helped raised $7 million early-stage funding from investors, developed pre-seed and seed business strategy in the field of gene therapy bioprocessing, drafted term sheets and agreements (>$50 million) for negotiation of pre-clinical out-licensing, MTAs and partnerships. As an angel investor, he has invested and led diligence at San Diego-based NuFund (formerly San Diego Tech Coast Angels) and Indiana-based VisionTech Angels and Partners. He served on several startup boards including Toralgen.
As a tenured professor at Indiana University, he conducted research in genetic and environmental risk factors of heart and neurological diseases in vulnerable populations. He was recognized as "40 Under 40 in Public Health" by the Washington DC-based de Beaumont Foundation and was awarded "Outstanding Individual Advancing Sustainability Award" by the Indianapolis Mayor's Office.
He attended the full-time MBA program as a Manning Scholar and received his MBA from Duke University. He received his PhD in Environmental Epidemiology at University of Michigan School of Public Health, followed by his postdoctoral training at Brown University School of Public Health. Prior to his PhD research, he was a bench scientist and received his Master's degree in Toxicology at University of California, Irvine and his Bachelor's degree in Bioengineering/BioPharmaceutical Sciences at Shenyang Pharmaceutical University in China.